- Home
- RVPH vs MULN Comparison
RVPH vs MULN Comparison
Compare RVPH & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- MULN
- Stock Information
- Founded
- RVPH 2006
- MULN 2014
- Country
- RVPH United States
- MULN United States
- Employees
- RVPH N/A
- MULN N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- MULN Auto Manufacturing
- Sector
- RVPH Health Care
- MULN Consumer Discretionary
- Exchange
- RVPH Nasdaq
- MULN Nasdaq
- Market Cap
- RVPH 32.8M
- MULN 6.5M
- IPO Year
- RVPH N/A
- MULN N/A
- Fundamental
- Price
- RVPH $0.37
- MULN $0.23
- Analyst Decision
- RVPH Strong Buy
- MULN
- Analyst Count
- RVPH 5
- MULN 0
- Target Price
- RVPH $9.00
- MULN N/A
- AVG Volume (30 Days)
- RVPH 2.6M
- MULN 9.9M
- Earning Date
- RVPH 08-13-2025
- MULN 08-11-2025
- Dividend Yield
- RVPH N/A
- MULN N/A
- EPS Growth
- RVPH N/A
- MULN N/A
- EPS
- RVPH N/A
- MULN N/A
- Revenue
- RVPH N/A
- MULN $8,931,612.00
- Revenue This Year
- RVPH N/A
- MULN N/A
- Revenue Next Year
- RVPH N/A
- MULN N/A
- P/E Ratio
- RVPH N/A
- MULN N/A
- Revenue Growth
- RVPH N/A
- MULN 2136.62
- 52 Week Low
- RVPH $0.30
- MULN $0.22
- 52 Week High
- RVPH $4.28
- MULN $150,000,000.00
- Technical
- Relative Strength Index (RSI)
- RVPH 30.28
- MULN 17.60
- Support Level
- RVPH $0.35
- MULN $1.62
- Resistance Level
- RVPH $0.83
- MULN $1.64
- Average True Range (ATR)
- RVPH 0.07
- MULN 0.36
- MACD
- RVPH -0.04
- MULN 102.39
- Stochastic Oscillator
- RVPH 11.32
- MULN 0.00
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.